Christopher Heeschen
Prof Heeschen obtained his Medical Degree in 1997 from the Free University of Berlin (Germany). And his PhD in 2001 from Stanford University (USA). Prof Heeschen became an independent investigator in 2004 as Professor of Experimental Oncology and Transplantation and Head of the Department Experimental at Ludwig-Maximilian-University in Munich (Germany). In 2008 he moved to the Spanish National Cancer Research Centre (CNIO) as a founding member of the Clinical Research Programme. In 2013, he became the lead of the new Centre for Stem Cells in Cancer & Ageing at Barts Cancer Institute, London, UK. In March 2018, Prof Heeschen was recruited to UNSW under the SHARP program to establish his translational research programme at the Lowy Cancer Research Institute (Randwick Campus) and the Ingham Institute (Liverpool Campus). Building on his original discovery of pancreatic cancer stem cells and the heterogeneity therein, his lab is now working on newly identified key epigenetic and metabolic regulators of the stemness signalling network in cancer stem cells. Please Stem Cells & Cancer Group for more details on his lab-based work.
Prof Heeschen has published more than 150 articles in prestigious scientific journals such as the New England Journal of Medicine, Nature Medicine, The Lancet, Cancer Cell, Cell Stem Cell, the Journal of Experimental Medicine, and PNAS, among others. His work has been cited more than 26,000 times (GoogleScholar). Prof Heeschen has made major original contributions to the field of stem and vascular cell biology that have advanced our understanding of the basic processes of stem cell function and trafficking. His research has been recognised through numerous international awards and has earned him an ERC Advanced Investigator Grant for pancreatic cancer research.
(Sun 16:00-18:00 Elston Room) Session 8: Pancreas and Cancer - Plenary
(16:15-16:45) Pancreatic and GI Cancer - Targeting Pancreatic Cancer Stem Cells to Prevent Disease Relapse
(back to speakers)
|
.jpg)